bioRxivImmunology
Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy
P. P. Cunha, E. Minogue, L. C. Krause, R. M. Hess, D. Bargiela, B. J. Wadsworth, L. Barbieri, C. Brombach, I. P. Foskolou, I. Bogeski, P. Velica, R. Johnson
Abstract
SummaryOxygenation levels are a determinative factor in T cell function. Here we describe that the oxygen tensions sensed by T cells at the moment of activation act to persistently modulate both differentiation and function. We found that in a protocol of CAR-T cell generation, 24 hours of low oxygen levels during initial CD8+ T cell priming is sufficient to enhance antitumour cytotoxicity in a preclinical model. This is the case even when CAR-T cells are subsequently cultured under high oxygen tensions prior to adoptive transfer. Increased hypoxia inducible transcription factor (HIF) expression was able to alter T cell fate in a similar manner to exposure to low oxygen tensions; however, only a controlled or temporary increase in HIF signalling was able to consistently improve cytotoxic function of T cells. These data show that oxygenation levels during and immediately after T cell activation play an essential role in regulating T cell function.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modified HIF expression in CD8+ T cells increases anti-tumor efficacy
P. Velica, P. P. Cunha, … R. S. Johnson·bioRxiv·Jun 18, 2020
- Systemic hypoxia inhibits T cell response by limiting mitobiogenesis via matrix substrate-level phosphorylation arrest
A. Saragovi, I. Abramovitch, … M. Berger·bioRxiv·Mar 19, 2020
- Local Oxygen Tension Dictates Hematopoietic Cell Growth and Potency
James P. Ropa, Sarah Gutch, … Maegan L. Capitano·LeukemiaPeer-reviewed·May 14, 2026
- Oxygen carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced suppression and improve cancer immunotherapy
K. Halpin-Veszeleiova, M. Mallouh, … S. M. Hatfield·bioRxiv·Feb 17, 2024
- Hypoxia is a dominant remodeler of the CD8+ T cell surface proteome relative to activation and regulatory T cell-mediated suppression
J. R. Byrnes, A. M. Weeks, … J. A. Wells·bioRxiv·Jun 7, 2021
- Coverslip Hypoxia High-Content Screening (CH-HCS): A 2D Imaging Platform for Spatially Resolved Analysis of CAR-T Function Under Oxygen Gradients
JPZ Murarolli, Giovana Beatriz Capuz Beatriz Capuz, … Rodrigo Alexandre Panepucci·bioRxiv·Feb 2, 2026